FDA moves toward easing restrictions on certain peptides BioPharma Dive In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for What Are Injectable Peptides? Here's Why Doctors Are Worried About the Latest TikTok Wellness Fad. WSJ BPC 157: The Promise and Perils of a Healing Peptide: Apple, Alex: 9798319471673: Amazon.com: Books RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn